Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
Department of Health and Human Services
Through this engineering-oriented Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to encourage submissions of exploratory/developmental Bioengineering Research Grant (EBRG) applications to demonstrate feasibility and potential utility of new capabilities or improvements in quality, speed, efficacy, operability, costs, and/or accessibility of solutions to problems in basic biomedical, pre-clinical, or clinical research, clinical care delivery, or accessibility.
Funding
Award size
Not specified
Type
Grant
Dates
Deadline
Later
Posted
12/10/2024
Closes
2028-01-07
Eligibility
Eligibility
County governmentsSpecial district governmentsPublic housing authorities/Indian housing authoritiesPublic and State controlled institutions of higher educationOthers (see text field entitled "Additional Information on Eligibility" for clarification)State governmentsSmall businessesNative American tribal governments (Federally recognized)For profit organizations other than small businessesCity or township governmentsIndependent school districtsNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationPrivate institutions of higher educationNonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Program
Funding area
Education - EDHealth - HL
Opportunity #
PAR-25-321
Source
Status
Open
Market
Government
Level
Federal
Source
Grants.gov